CAS: 2289691-01-4
MYCi975
CAS:2289691-01-4
MYCi975 (NUCC-0200975) is an orally active inhibitor of MYC.
Fórmula:
C25H16Cl2F6N2O2
Pureza:
99.3%
Forma y color:
Solid
Peso molecular:
561.3
Ref: TM-T12133
| 1mg | 122,00 € | |
| 5mg | 276,00 € | |
| 10mg | 460,00 € | |
| 25mg | 761,00 € | |
| 50mg | 1.054,00 € | |
| 100mg | 1.425,00 € | |
| 500mg | 2.757,00 € | |
| 1ml*10 (DMSO) | 356,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
![4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol](https://static.cymitquimica.com/products/AN/thumb/AG01KL4V.jpg)
4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol
CAS:2289691-01-4
Fórmula:
C25H16Cl2F6N2O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
561.3032
Ref: AN-AG01KL4V
| 1g | 1.734,00 € | |
| 25mg | 187,00 € | |
| 50mg | 226,00 € | |
| 100mg | 508,00 € | |
| 250mg | 609,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
MYCi975
CAS:2289691-01-4
MYCi975 is a drug candidate in the development of cancer-targeted therapies. MYCi975 binds to and …
Fórmula:
C25H16Cl2F6N2O2
Pureza:
Min. 95%
Peso molecular:
561.3 g/mol
Ref: 3D-PRD69101
| 1mg | 92,00 € | |
| 5mg | 240,00 € | |
| 10mg | 360,00 € | |
| 25mg | 601,00 € | |
| 50mg | 915,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
